Events & Presentations
June 10, 2024
Panbela Announces Oral Presentation at Digestive Disease Week (DDW)
Evaluation of the Safety and Efficacy of Eflornithine (Difluoromethylornithine, DFMO) in Patients with Gastric Premalignant Conditions in the High Incidence Areas of Latin America
April 30, 2024
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week (DDW)
April 18, 2024
Panbela Announces Poster Presentation at American Association for Cancer Research
Ivospemin/doxorubicin combination modulates polyamine metabolism to improve survival in murine ovarian cancer models
View/download poster presentation »
January 30, 2024
Acceptance of Ivospemin (SBP-101) Abstract for Poster Presentation at American Association for Cancer Research (AACR)
October 25, 2023
Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online Publication
September 19, 2023
Panbela to Present at the LD Micro Investor Conference
August 28, 2023
Panbela to Present at H.C. Wainwright 25th Annual Global Investment Conference
June 26, 2023
Panbela Announces Poster Presentation at the Endocrine Society Meeting
Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes
View/download poster presentation »
June 1, 2023
Panbela Announces Poster Presentation at Immunology of Diabetes Society Meeting
Evaluating the Potential of CPP-1X (Eflornithine) in Recent Onset Type 1 Diabetes
April 19, 2023
Panbela Announces Poster Presentation at American Association for Cancer Research
Evaluating the potential of spermine analogue ivospemin (SBP-101) in combination with chemotherapy in ovarian cancer
View/download poster presentation »
April 10, 2023
Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Immunology of Diabetes Society Meeting
April 6, 2023
Acceptance of CPP-1X (DFMO) Abstract for Poster Presentation at Endocrine Society Meeting
March 1, 2023
Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)
April 12, 2022
Panbela Announces Poster Presentation at American Association for Cancer Research: The potential of spermine analogue SBP-101 (diethyl dihydroxyhomospermine) as a polyamine metabolism modulator in ovarian cancer
View/download poster presentation »
March 23, 2022
Panbela to Participate in a Panel Discussion: “Pancreatic Cancer- Turning the Tide for One of the Most Challenging Indications in Oncology,” at the Maxim Virtual Growth Conference on March 28 at 12pm ET
March 10, 2022
Panbela to Participate in the 34th Annual Roth Conference
- Panbela management will participate in a fireside chat at the 34th Annual Roth Conference on March 14, 2022, at 11:30AM PT.
- The webcast will be available at: https://wsw.com/webcast/roth43/pbla/1805948
March 7, 2022
Acceptance of SBP-101 Abstract for Poster Presentation at American Association for Cancer Research (AACR)
January 24, 2022
Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2022 ASCO GI Meeting
Interim data presented in poster reflects median overall survival of 12.0 months, not yet final, and an objective response rate of 48%, both greater than historical rates reported for standard of care
View/download poster presentation »
November 18, 2021
Panbela Announces Acceptance of Abstract for Poster Presentation at American Society of Clinical Oncology Gastrointestinal Cancers Symposium
September 7, 2021
Panbela to Present at Upcoming Investor Conferences
H.C. Wainwright 23rd Annual Global Investment Conference: September 13th to 15th, 2021
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: September 20-23
July 7, 2021
Panbela to Present at Access to Giving Virtual Conference July 15 at 10:30 a.m. ET
June 4, 2021
Panbela Presents Clinical Data on Phase 1b Clinical Trial of SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic PDA at 2021 ASCO Annual Meeting
View/download poster presentation »
November 10, 2020
SBP to Participate in the 11th Annual Craig-Hallum Alpha Select Conference
January 24, 2020
SBP Summarizes SBP-101 Phase 1 Clinical Data Presented at ASCO 2020 Annual Gastrointestinal Cancers Symposium
- SBP-101 was well tolerated in combination with gemcitabine and nab-paclitaxel
- Objective Response Rate (ORR) was 62% by RECIST criteria
- Study expansion in patients with pancreatic cancer planned to begin in Q2
View/download press release »
View/download poster presentation »
December 22, 2019
SBP Announces Data Presentation at the ASCO 2020 Annual Gastrointestinal Cancers Symposium
Biotech Executive Arthur Fratamico Recently Joined Board of Directors
View/download press release »
View/download poster presentation »
November 1, 2018
SBP to Present Results of New Study at American Pancreatic Association Meeting
New study entitled “Effect of SBP-101 in a Mouse Model of Cerulein-induced Acute Pancreatitis” will be presented at the American Pancreatic Association meeting in Miami, FL on Nov. 1.
View/download press release »
View/download poster presentation »
July 27, 2018
SBP Presents Poster at PancreasFest in Pittsburgh PA
- Results of Phase 1 Safety Study of SBP-101 for Pancreatic Ductal Adenocarcinoma
- PancreasFest is an International Conference of Physicians and Scientists Focused on Pancreatic Diseases
View/download press release »
View/download poster presentation »
June 7, 2017
SBP to Present at the 2017 Marcum MicroCap Conference on June 15
October 24, 2016
SBP to Present at the Innovation Biotech Showcase October 26
November 9, 2015
Compelling Preclinical Data on Sun BioPharma’s SBP-101 Presented at APA Annual Meeting
February 28, 2015
APA 2015
Sun BioPharma will participate in the poster session at the American Pancreatic Association Annual Meeting on 4-7 November, 2015 in San Diego, CA.
For more information please visit their website at www.american-pancreatic-association.org
February 28, 2015
PancreasFest 2015
Sun BioPharma participated in the poster session at PancreasFest on 22-24 July 2015 in Pittsburgh, PA.
A joint meeting of physicians and scientists committed to learning and collaborating on translational studies of pancreatic diseases.
For more information, please visit their website at pancreasfest.com
Press Releases